[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Anti-erectile Dysfunction (ED) Drugs Supply, Demand and Key Producers, 2023-2029

April 2023 | 120 pages | ID: G3D4C0CA65F9EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
The global Anti-erectile Dysfunction (ED) Drugs market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).

This report studies the global Anti-erectile Dysfunction (ED) Drugs production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Anti-erectile Dysfunction (ED) Drugs, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Anti-erectile Dysfunction (ED) Drugs that contribute to its increasing demand across many markets.

Highlights and key features of the study

Global Anti-erectile Dysfunction (ED) Drugs total production and demand, 2018-2029, (K Units)

Global Anti-erectile Dysfunction (ED) Drugs total production value, 2018-2029, (USD Million)

Global Anti-erectile Dysfunction (ED) Drugs production by region & country, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Anti-erectile Dysfunction (ED) Drugs consumption by region & country, CAGR, 2018-2029 & (K Units)

U.S. VS China: Anti-erectile Dysfunction (ED) Drugs domestic production, consumption, key domestic manufacturers and share

Global Anti-erectile Dysfunction (ED) Drugs production by manufacturer, production, price, value and market share 2018-2023, (USD Million) & (K Units)

Global Anti-erectile Dysfunction (ED) Drugs production by Type, production, value, CAGR, 2018-2029, (USD Million) & (K Units)

Global Anti-erectile Dysfunction (ED) Drugs production by Application production, value, CAGR, 2018-2029, (USD Million) & (K Units)

This reports profiles key players in the global Anti-erectile Dysfunction (ED) Drugs market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Vivus, Inc., Lilly ICOS LLC, Pfizer, Bayer, Hims, Menarini Group, Lupin, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd and General Factory, etc.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Anti-erectile Dysfunction (ED) Drugs market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (K Units) and average price (US$/Unit) by manufacturer, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.

Global Anti-erectile Dysfunction (ED) Drugs Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
  • Rest of World
Global Anti-erectile Dysfunction (ED) Drugs Market, Segmentation by Type
  • Sildenafil (Viagra)
  • Vardenafil (Levitra, Staxyn)
  • Tadalafil (Cialis)
  • Avanafil (Stendra)
  • Udenafil (Zydena)
  • Others
Global Anti-erectile Dysfunction (ED) Drugs Market, Segmentation by Application
  • Hospital
  • Retail Pharmacy
  • Clinic
  • Online Pharmacy
Companies Profiled:
  • Vivus, Inc.
  • Lilly ICOS LLC
  • Pfizer
  • Bayer
  • Hims
  • Menarini Group
  • Lupin
  • Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
  • General Factory
  • CSBio
  • Dong-A ST
  • Metuchen Pharma
  • Seoul Pharma
  • Teva Pharma
  • S.K. Chemicals
Key Questions Answered

1. How big is the global Anti-erectile Dysfunction (ED) Drugs market?

2. What is the demand of the global Anti-erectile Dysfunction (ED) Drugs market?

3. What is the year over year growth of the global Anti-erectile Dysfunction (ED) Drugs market?

4. What is the production and production value of the global Anti-erectile Dysfunction (ED) Drugs market?

5. Who are the key producers in the global Anti-erectile Dysfunction (ED) Drugs market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Anti-erectile Dysfunction (ED) Drugs Introduction
1.2 World Anti-erectile Dysfunction (ED) Drugs Supply & Forecast
  1.2.1 World Anti-erectile Dysfunction (ED) Drugs Production Value (2018 & 2022 & 2029)
  1.2.2 World Anti-erectile Dysfunction (ED) Drugs Production (2018-2029)
  1.2.3 World Anti-erectile Dysfunction (ED) Drugs Pricing Trends (2018-2029)
1.3 World Anti-erectile Dysfunction (ED) Drugs Production by Region (Based on Production Site)
  1.3.1 World Anti-erectile Dysfunction (ED) Drugs Production Value by Region (2018-2029)
  1.3.2 World Anti-erectile Dysfunction (ED) Drugs Production by Region (2018-2029)
  1.3.3 World Anti-erectile Dysfunction (ED) Drugs Average Price by Region (2018-2029)
  1.3.4 North America Anti-erectile Dysfunction (ED) Drugs Production (2018-2029)
  1.3.5 Europe Anti-erectile Dysfunction (ED) Drugs Production (2018-2029)
  1.3.6 China Anti-erectile Dysfunction (ED) Drugs Production (2018-2029)
  1.3.7 Japan Anti-erectile Dysfunction (ED) Drugs Production (2018-2029)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Anti-erectile Dysfunction (ED) Drugs Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Anti-erectile Dysfunction (ED) Drugs Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Anti-erectile Dysfunction (ED) Drugs Demand (2018-2029)
2.2 World Anti-erectile Dysfunction (ED) Drugs Consumption by Region
  2.2.1 World Anti-erectile Dysfunction (ED) Drugs Consumption by Region (2018-2023)
  2.2.2 World Anti-erectile Dysfunction (ED) Drugs Consumption Forecast by Region (2024-2029)
2.3 United States Anti-erectile Dysfunction (ED) Drugs Consumption (2018-2029)
2.4 China Anti-erectile Dysfunction (ED) Drugs Consumption (2018-2029)
2.5 Europe Anti-erectile Dysfunction (ED) Drugs Consumption (2018-2029)
2.6 Japan Anti-erectile Dysfunction (ED) Drugs Consumption (2018-2029)
2.7 South Korea Anti-erectile Dysfunction (ED) Drugs Consumption (2018-2029)
2.8 ASEAN Anti-erectile Dysfunction (ED) Drugs Consumption (2018-2029)
2.9 India Anti-erectile Dysfunction (ED) Drugs Consumption (2018-2029)

3 WORLD ANTI-ERECTILE DYSFUNCTION (ED) DRUGS MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Anti-erectile Dysfunction (ED) Drugs Production Value by Manufacturer (2018-2023)
3.2 World Anti-erectile Dysfunction (ED) Drugs Production by Manufacturer (2018-2023)
3.3 World Anti-erectile Dysfunction (ED) Drugs Average Price by Manufacturer (2018-2023)
3.4 Anti-erectile Dysfunction (ED) Drugs Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Anti-erectile Dysfunction (ED) Drugs Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Anti-erectile Dysfunction (ED) Drugs in 2022
  3.5.3 Global Concentration Ratios (CR8) for Anti-erectile Dysfunction (ED) Drugs in 2022
3.6 Anti-erectile Dysfunction (ED) Drugs Market: Overall Company Footprint Analysis
  3.6.1 Anti-erectile Dysfunction (ED) Drugs Market: Region Footprint
  3.6.2 Anti-erectile Dysfunction (ED) Drugs Market: Company Product Type Footprint
  3.6.3 Anti-erectile Dysfunction (ED) Drugs Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Anti-erectile Dysfunction (ED) Drugs Production Value Comparison
  4.1.1 United States VS China: Anti-erectile Dysfunction (ED) Drugs Production Value Comparison (2018 & 2022 & 2029)
  4.1.2 United States VS China: Anti-erectile Dysfunction (ED) Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
4.2 United States VS China: Anti-erectile Dysfunction (ED) Drugs Production Comparison
  4.2.1 United States VS China: Anti-erectile Dysfunction (ED) Drugs Production Comparison (2018 & 2022 & 2029)
  4.2.2 United States VS China: Anti-erectile Dysfunction (ED) Drugs Production Market Share Comparison (2018 & 2022 & 2029)
4.3 United States VS China: Anti-erectile Dysfunction (ED) Drugs Consumption Comparison
  4.3.1 United States VS China: Anti-erectile Dysfunction (ED) Drugs Consumption Comparison (2018 & 2022 & 2029)
  4.3.2 United States VS China: Anti-erectile Dysfunction (ED) Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
4.4 United States Based Anti-erectile Dysfunction (ED) Drugs Manufacturers and Market Share, 2018-2023
  4.4.1 United States Based Anti-erectile Dysfunction (ED) Drugs Manufacturers, Headquarters and Production Site (States, Country)
  4.4.2 United States Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production Value (2018-2023)
  4.4.3 United States Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production (2018-2023)
4.5 China Based Anti-erectile Dysfunction (ED) Drugs Manufacturers and Market Share
  4.5.1 China Based Anti-erectile Dysfunction (ED) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
  4.5.2 China Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production Value (2018-2023)
  4.5.3 China Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production (2018-2023)
4.6 Rest of World Based Anti-erectile Dysfunction (ED) Drugs Manufacturers and Market Share, 2018-2023
  4.6.1 Rest of World Based Anti-erectile Dysfunction (ED) Drugs Manufacturers, Headquarters and Production Site (State, Country)
  4.6.2 Rest of World Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production Value (2018-2023)
  4.6.3 Rest of World Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production (2018-2023)

5 MARKET ANALYSIS BY TYPE

5.1 World Anti-erectile Dysfunction (ED) Drugs Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
  5.2.1 Sildenafil (Viagra)
  5.2.2 Vardenafil (Levitra, Staxyn)
  5.2.3 Tadalafil (Cialis)
  5.2.4 Avanafil (Stendra)
  5.2.5 Udenafil (Zydena)
  5.2.6 Others
5.3 Market Segment by Type
  5.3.1 World Anti-erectile Dysfunction (ED) Drugs Production by Type (2018-2029)
  5.3.2 World Anti-erectile Dysfunction (ED) Drugs Production Value by Type (2018-2029)
  5.3.3 World Anti-erectile Dysfunction (ED) Drugs Average Price by Type (2018-2029)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Anti-erectile Dysfunction (ED) Drugs Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
  6.2.1 Hospital
  6.2.2 Retail Pharmacy
  6.2.3 Clinic
  6.2.4 Online Pharmacy
6.3 Market Segment by Application
  6.3.1 World Anti-erectile Dysfunction (ED) Drugs Production by Application (2018-2029)
  6.3.2 World Anti-erectile Dysfunction (ED) Drugs Production Value by Application (2018-2029)
  6.3.3 World Anti-erectile Dysfunction (ED) Drugs Average Price by Application (2018-2029)

7 COMPANY PROFILES

7.1 Vivus, Inc.
  7.1.1 Vivus, Inc. Details
  7.1.2 Vivus, Inc. Major Business
  7.1.3 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product and Services
  7.1.4 Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.1.5 Vivus, Inc. Recent Developments/Updates
  7.1.6 Vivus, Inc. Competitive Strengths & Weaknesses
7.2 Lilly ICOS LLC
  7.2.1 Lilly ICOS LLC Details
  7.2.2 Lilly ICOS LLC Major Business
  7.2.3 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product and Services
  7.2.4 Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.2.5 Lilly ICOS LLC Recent Developments/Updates
  7.2.6 Lilly ICOS LLC Competitive Strengths & Weaknesses
7.3 Pfizer
  7.3.1 Pfizer Details
  7.3.2 Pfizer Major Business
  7.3.3 Pfizer Anti-erectile Dysfunction (ED) Drugs Product and Services
  7.3.4 Pfizer Anti-erectile Dysfunction (ED) Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.3.5 Pfizer Recent Developments/Updates
  7.3.6 Pfizer Competitive Strengths & Weaknesses
7.4 Bayer
  7.4.1 Bayer Details
  7.4.2 Bayer Major Business
  7.4.3 Bayer Anti-erectile Dysfunction (ED) Drugs Product and Services
  7.4.4 Bayer Anti-erectile Dysfunction (ED) Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.4.5 Bayer Recent Developments/Updates
  7.4.6 Bayer Competitive Strengths & Weaknesses
7.5 Hims
  7.5.1 Hims Details
  7.5.2 Hims Major Business
  7.5.3 Hims Anti-erectile Dysfunction (ED) Drugs Product and Services
  7.5.4 Hims Anti-erectile Dysfunction (ED) Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.5.5 Hims Recent Developments/Updates
  7.5.6 Hims Competitive Strengths & Weaknesses
7.6 Menarini Group
  7.6.1 Menarini Group Details
  7.6.2 Menarini Group Major Business
  7.6.3 Menarini Group Anti-erectile Dysfunction (ED) Drugs Product and Services
  7.6.4 Menarini Group Anti-erectile Dysfunction (ED) Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.6.5 Menarini Group Recent Developments/Updates
  7.6.6 Menarini Group Competitive Strengths & Weaknesses
7.7 Lupin
  7.7.1 Lupin Details
  7.7.2 Lupin Major Business
  7.7.3 Lupin Anti-erectile Dysfunction (ED) Drugs Product and Services
  7.7.4 Lupin Anti-erectile Dysfunction (ED) Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.7.5 Lupin Recent Developments/Updates
  7.7.6 Lupin Competitive Strengths & Weaknesses
7.8 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
  7.8.1 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Details
  7.8.2 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Major Business
  7.8.3 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product and Services
  7.8.4 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.8.5 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments/Updates
  7.8.6 Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitive Strengths & Weaknesses
7.9 General Factory
  7.9.1 General Factory Details
  7.9.2 General Factory Major Business
  7.9.3 General Factory Anti-erectile Dysfunction (ED) Drugs Product and Services
  7.9.4 General Factory Anti-erectile Dysfunction (ED) Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.9.5 General Factory Recent Developments/Updates
  7.9.6 General Factory Competitive Strengths & Weaknesses
7.10 CSBio
  7.10.1 CSBio Details
  7.10.2 CSBio Major Business
  7.10.3 CSBio Anti-erectile Dysfunction (ED) Drugs Product and Services
  7.10.4 CSBio Anti-erectile Dysfunction (ED) Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.10.5 CSBio Recent Developments/Updates
  7.10.6 CSBio Competitive Strengths & Weaknesses
7.11 Dong-A ST
  7.11.1 Dong-A ST Details
  7.11.2 Dong-A ST Major Business
  7.11.3 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product and Services
  7.11.4 Dong-A ST Anti-erectile Dysfunction (ED) Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.11.5 Dong-A ST Recent Developments/Updates
  7.11.6 Dong-A ST Competitive Strengths & Weaknesses
7.12 Metuchen Pharma
  7.12.1 Metuchen Pharma Details
  7.12.2 Metuchen Pharma Major Business
  7.12.3 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
  7.12.4 Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.12.5 Metuchen Pharma Recent Developments/Updates
  7.12.6 Metuchen Pharma Competitive Strengths & Weaknesses
7.13 Seoul Pharma
  7.13.1 Seoul Pharma Details
  7.13.2 Seoul Pharma Major Business
  7.13.3 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
  7.13.4 Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.13.5 Seoul Pharma Recent Developments/Updates
  7.13.6 Seoul Pharma Competitive Strengths & Weaknesses
7.14 Teva Pharma
  7.14.1 Teva Pharma Details
  7.14.2 Teva Pharma Major Business
  7.14.3 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
  7.14.4 Teva Pharma Anti-erectile Dysfunction (ED) Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.14.5 Teva Pharma Recent Developments/Updates
  7.14.6 Teva Pharma Competitive Strengths & Weaknesses
7.15 S.K. Chemicals
  7.15.1 S.K. Chemicals Details
  7.15.2 S.K. Chemicals Major Business
  7.15.3 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product and Services
  7.15.4 S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Production, Price, Value, Gross Margin and Market Share (2018-2023)
  7.15.5 S.K. Chemicals Recent Developments/Updates
  7.15.6 S.K. Chemicals Competitive Strengths & Weaknesses

8 INDUSTRY CHAIN ANALYSIS

8.1 Anti-erectile Dysfunction (ED) Drugs Industry Chain
8.2 Anti-erectile Dysfunction (ED) Drugs Upstream Analysis
  8.2.1 Anti-erectile Dysfunction (ED) Drugs Core Raw Materials
  8.2.2 Main Manufacturers of Anti-erectile Dysfunction (ED) Drugs Core Raw Materials
8.3 Midstream Analysis
8.4 Downstream Analysis
8.5 Anti-erectile Dysfunction (ED) Drugs Production Mode
8.6 Anti-erectile Dysfunction (ED) Drugs Procurement Model
8.7 Anti-erectile Dysfunction (ED) Drugs Industry Sales Model and Sales Channels
  8.7.1 Anti-erectile Dysfunction (ED) Drugs Sales Model
  8.7.2 Anti-erectile Dysfunction (ED) Drugs Typical Customers

9 RESEARCH FINDINGS AND CONCLUSION

10 APPENDIX

10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer

LIST OF TABLES

Table 1. World Anti-erectile Dysfunction (ED) Drugs Production Value by Region (2018, 2022 and 2029) & (USD Million)
Table 2. World Anti-erectile Dysfunction (ED) Drugs Production Value by Region (2018-2023) & (USD Million)
Table 3. World Anti-erectile Dysfunction (ED) Drugs Production Value by Region (2024-2029) & (USD Million)
Table 4. World Anti-erectile Dysfunction (ED) Drugs Production Value Market Share by Region (2018-2023)
Table 5. World Anti-erectile Dysfunction (ED) Drugs Production Value Market Share by Region (2024-2029)
Table 6. World Anti-erectile Dysfunction (ED) Drugs Production by Region (2018-2023) & (K Units)
Table 7. World Anti-erectile Dysfunction (ED) Drugs Production by Region (2024-2029) & (K Units)
Table 8. World Anti-erectile Dysfunction (ED) Drugs Production Market Share by Region (2018-2023)
Table 9. World Anti-erectile Dysfunction (ED) Drugs Production Market Share by Region (2024-2029)
Table 10. World Anti-erectile Dysfunction (ED) Drugs Average Price by Region (2018-2023) & (US$/Unit)
Table 11. World Anti-erectile Dysfunction (ED) Drugs Average Price by Region (2024-2029) & (US$/Unit)
Table 12. Anti-erectile Dysfunction (ED) Drugs Major Market Trends
Table 13. World Anti-erectile Dysfunction (ED) Drugs Consumption Growth Rate Forecast by Region (2018 & 2022 & 2029) & (K Units)
Table 14. World Anti-erectile Dysfunction (ED) Drugs Consumption by Region (2018-2023) & (K Units)
Table 15. World Anti-erectile Dysfunction (ED) Drugs Consumption Forecast by Region (2024-2029) & (K Units)
Table 16. World Anti-erectile Dysfunction (ED) Drugs Production Value by Manufacturer (2018-2023) & (USD Million)
Table 17. Production Value Market Share of Key Anti-erectile Dysfunction (ED) Drugs Producers in 2022
Table 18. World Anti-erectile Dysfunction (ED) Drugs Production by Manufacturer (2018-2023) & (K Units)
Table 19. Production Market Share of Key Anti-erectile Dysfunction (ED) Drugs Producers in 2022
Table 20. World Anti-erectile Dysfunction (ED) Drugs Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 21. Global Anti-erectile Dysfunction (ED) Drugs Company Evaluation Quadrant
Table 22. World Anti-erectile Dysfunction (ED) Drugs Industry Rank of Major Manufacturers, Based on Production Value in 2022
Table 23. Head Office and Anti-erectile Dysfunction (ED) Drugs Production Site of Key Manufacturer
Table 24. Anti-erectile Dysfunction (ED) Drugs Market: Company Product Type Footprint
Table 25. Anti-erectile Dysfunction (ED) Drugs Market: Company Product Application Footprint
Table 26. Anti-erectile Dysfunction (ED) Drugs Competitive Factors
Table 27. Anti-erectile Dysfunction (ED) Drugs New Entrant and Capacity Expansion Plans
Table 28. Anti-erectile Dysfunction (ED) Drugs Mergers & Acquisitions Activity
Table 29. United States VS China Anti-erectile Dysfunction (ED) Drugs Production Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 30. United States VS China Anti-erectile Dysfunction (ED) Drugs Production Comparison, (2018 & 2022 & 2029) & (K Units)
Table 31. United States VS China Anti-erectile Dysfunction (ED) Drugs Consumption Comparison, (2018 & 2022 & 2029) & (K Units)
Table 32. United States Based Anti-erectile Dysfunction (ED) Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 33. United States Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production Value, (2018-2023) & (USD Million)
Table 34. United States Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production Value Market Share (2018-2023)
Table 35. United States Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production (2018-2023) & (K Units)
Table 36. United States Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production Market Share (2018-2023)
Table 37. China Based Anti-erectile Dysfunction (ED) Drugs Manufacturers, Headquarters and Production Site (Province, Country)
Table 38. China Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production Value, (2018-2023) & (USD Million)
Table 39. China Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production Value Market Share (2018-2023)
Table 40. China Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production (2018-2023) & (K Units)
Table 41. China Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production Market Share (2018-2023)
Table 42. Rest of World Based Anti-erectile Dysfunction (ED) Drugs Manufacturers, Headquarters and Production Site (States, Country)
Table 43. Rest of World Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production Value, (2018-2023) & (USD Million)
Table 44. Rest of World Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production Value Market Share (2018-2023)
Table 45. Rest of World Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production (2018-2023) & (K Units)
Table 46. Rest of World Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production Market Share (2018-2023)
Table 47. World Anti-erectile Dysfunction (ED) Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Table 48. World Anti-erectile Dysfunction (ED) Drugs Production by Type (2018-2023) & (K Units)
Table 49. World Anti-erectile Dysfunction (ED) Drugs Production by Type (2024-2029) & (K Units)
Table 50. World Anti-erectile Dysfunction (ED) Drugs Production Value by Type (2018-2023) & (USD Million)
Table 51. World Anti-erectile Dysfunction (ED) Drugs Production Value by Type (2024-2029) & (USD Million)
Table 52. World Anti-erectile Dysfunction (ED) Drugs Average Price by Type (2018-2023) & (US$/Unit)
Table 53. World Anti-erectile Dysfunction (ED) Drugs Average Price by Type (2024-2029) & (US$/Unit)
Table 54. World Anti-erectile Dysfunction (ED) Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Table 55. World Anti-erectile Dysfunction (ED) Drugs Production by Application (2018-2023) & (K Units)
Table 56. World Anti-erectile Dysfunction (ED) Drugs Production by Application (2024-2029) & (K Units)
Table 57. World Anti-erectile Dysfunction (ED) Drugs Production Value by Application (2018-2023) & (USD Million)
Table 58. World Anti-erectile Dysfunction (ED) Drugs Production Value by Application (2024-2029) & (USD Million)
Table 59. World Anti-erectile Dysfunction (ED) Drugs Average Price by Application (2018-2023) & (US$/Unit)
Table 60. World Anti-erectile Dysfunction (ED) Drugs Average Price by Application (2024-2029) & (US$/Unit)
Table 61. Vivus, Inc. Basic Information, Manufacturing Base and Competitors
Table 62. Vivus, Inc. Major Business
Table 63. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 64. Vivus, Inc. Anti-erectile Dysfunction (ED) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 65. Vivus, Inc. Recent Developments/Updates
Table 66. Vivus, Inc. Competitive Strengths & Weaknesses
Table 67. Lilly ICOS LLC Basic Information, Manufacturing Base and Competitors
Table 68. Lilly ICOS LLC Major Business
Table 69. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 70. Lilly ICOS LLC Anti-erectile Dysfunction (ED) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 71. Lilly ICOS LLC Recent Developments/Updates
Table 72. Lilly ICOS LLC Competitive Strengths & Weaknesses
Table 73. Pfizer Basic Information, Manufacturing Base and Competitors
Table 74. Pfizer Major Business
Table 75. Pfizer Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 76. Pfizer Anti-erectile Dysfunction (ED) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. Pfizer Recent Developments/Updates
Table 78. Pfizer Competitive Strengths & Weaknesses
Table 79. Bayer Basic Information, Manufacturing Base and Competitors
Table 80. Bayer Major Business
Table 81. Bayer Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 82. Bayer Anti-erectile Dysfunction (ED) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 83. Bayer Recent Developments/Updates
Table 84. Bayer Competitive Strengths & Weaknesses
Table 85. Hims Basic Information, Manufacturing Base and Competitors
Table 86. Hims Major Business
Table 87. Hims Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 88. Hims Anti-erectile Dysfunction (ED) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 89. Hims Recent Developments/Updates
Table 90. Hims Competitive Strengths & Weaknesses
Table 91. Menarini Group Basic Information, Manufacturing Base and Competitors
Table 92. Menarini Group Major Business
Table 93. Menarini Group Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 94. Menarini Group Anti-erectile Dysfunction (ED) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 95. Menarini Group Recent Developments/Updates
Table 96. Menarini Group Competitive Strengths & Weaknesses
Table 97. Lupin Basic Information, Manufacturing Base and Competitors
Table 98. Lupin Major Business
Table 99. Lupin Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 100. Lupin Anti-erectile Dysfunction (ED) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 101. Lupin Recent Developments/Updates
Table 102. Lupin Competitive Strengths & Weaknesses
Table 103. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Basic Information, Manufacturing Base and Competitors
Table 104. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Major Business
Table 105. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 106. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Anti-erectile Dysfunction (ED) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 107. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Recent Developments/Updates
Table 108. Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Competitive Strengths & Weaknesses
Table 109. General Factory Basic Information, Manufacturing Base and Competitors
Table 110. General Factory Major Business
Table 111. General Factory Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 112. General Factory Anti-erectile Dysfunction (ED) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 113. General Factory Recent Developments/Updates
Table 114. General Factory Competitive Strengths & Weaknesses
Table 115. CSBio Basic Information, Manufacturing Base and Competitors
Table 116. CSBio Major Business
Table 117. CSBio Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 118. CSBio Anti-erectile Dysfunction (ED) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 119. CSBio Recent Developments/Updates
Table 120. CSBio Competitive Strengths & Weaknesses
Table 121. Dong-A ST Basic Information, Manufacturing Base and Competitors
Table 122. Dong-A ST Major Business
Table 123. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 124. Dong-A ST Anti-erectile Dysfunction (ED) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 125. Dong-A ST Recent Developments/Updates
Table 126. Dong-A ST Competitive Strengths & Weaknesses
Table 127. Metuchen Pharma Basic Information, Manufacturing Base and Competitors
Table 128. Metuchen Pharma Major Business
Table 129. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 130. Metuchen Pharma Anti-erectile Dysfunction (ED) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 131. Metuchen Pharma Recent Developments/Updates
Table 132. Metuchen Pharma Competitive Strengths & Weaknesses
Table 133. Seoul Pharma Basic Information, Manufacturing Base and Competitors
Table 134. Seoul Pharma Major Business
Table 135. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 136. Seoul Pharma Anti-erectile Dysfunction (ED) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 137. Seoul Pharma Recent Developments/Updates
Table 138. Seoul Pharma Competitive Strengths & Weaknesses
Table 139. Teva Pharma Basic Information, Manufacturing Base and Competitors
Table 140. Teva Pharma Major Business
Table 141. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 142. Teva Pharma Anti-erectile Dysfunction (ED) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 143. Teva Pharma Recent Developments/Updates
Table 144. S.K. Chemicals Basic Information, Manufacturing Base and Competitors
Table 145. S.K. Chemicals Major Business
Table 146. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Product and Services
Table 147. S.K. Chemicals Anti-erectile Dysfunction (ED) Drugs Production (K Units), Price (US$/Unit), Production Value (USD Million), Gross Margin and Market Share (2018-2023)
Table 148. Global Key Players of Anti-erectile Dysfunction (ED) Drugs Upstream (Raw Materials)
Table 149. Anti-erectile Dysfunction (ED) Drugs Typical Customers
Table 150. Anti-erectile Dysfunction (ED) Drugs Typical Distributors

LIST OF FIGURES

Figure 1. Anti-erectile Dysfunction (ED) Drugs Picture
Figure 2. World Anti-erectile Dysfunction (ED) Drugs Production Value: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Anti-erectile Dysfunction (ED) Drugs Production Value and Forecast (2018-2029) & (USD Million)
Figure 4. World Anti-erectile Dysfunction (ED) Drugs Production (2018-2029) & (K Units)
Figure 5. World Anti-erectile Dysfunction (ED) Drugs Average Price (2018-2029) & (US$/Unit)
Figure 6. World Anti-erectile Dysfunction (ED) Drugs Production Value Market Share by Region (2018-2029)
Figure 7. World Anti-erectile Dysfunction (ED) Drugs Production Market Share by Region (2018-2029)
Figure 8. North America Anti-erectile Dysfunction (ED) Drugs Production (2018-2029) & (K Units)
Figure 9. Europe Anti-erectile Dysfunction (ED) Drugs Production (2018-2029) & (K Units)
Figure 10. China Anti-erectile Dysfunction (ED) Drugs Production (2018-2029) & (K Units)
Figure 11. Japan Anti-erectile Dysfunction (ED) Drugs Production (2018-2029) & (K Units)
Figure 12. Anti-erectile Dysfunction (ED) Drugs Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Anti-erectile Dysfunction (ED) Drugs Consumption (2018-2029) & (K Units)
Figure 15. World Anti-erectile Dysfunction (ED) Drugs Consumption Market Share by Region (2018-2029)
Figure 16. United States Anti-erectile Dysfunction (ED) Drugs Consumption (2018-2029) & (K Units)
Figure 17. China Anti-erectile Dysfunction (ED) Drugs Consumption (2018-2029) & (K Units)
Figure 18. Europe Anti-erectile Dysfunction (ED) Drugs Consumption (2018-2029) & (K Units)
Figure 19. Japan Anti-erectile Dysfunction (ED) Drugs Consumption (2018-2029) & (K Units)
Figure 20. South Korea Anti-erectile Dysfunction (ED) Drugs Consumption (2018-2029) & (K Units)
Figure 21. ASEAN Anti-erectile Dysfunction (ED) Drugs Consumption (2018-2029) & (K Units)
Figure 22. India Anti-erectile Dysfunction (ED) Drugs Consumption (2018-2029) & (K Units)
Figure 23. Producer Shipments of Anti-erectile Dysfunction (ED) Drugs by Manufacturer Revenue ($MM) and Market Share (%): 2022
Figure 24. Global Four-firm Concentration Ratios (CR4) for Anti-erectile Dysfunction (ED) Drugs Markets in 2022
Figure 25. Global Four-firm Concentration Ratios (CR8) for Anti-erectile Dysfunction (ED) Drugs Markets in 2022
Figure 26. United States VS China: Anti-erectile Dysfunction (ED) Drugs Production Value Market Share Comparison (2018 & 2022 & 2029)
Figure 27. United States VS China: Anti-erectile Dysfunction (ED) Drugs Production Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Anti-erectile Dysfunction (ED) Drugs Consumption Market Share Comparison (2018 & 2022 & 2029)
Figure 29. United States Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production Market Share 2022
Figure 30. China Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production Market Share 2022
Figure 31. Rest of World Based Manufacturers Anti-erectile Dysfunction (ED) Drugs Production Market Share 2022
Figure 32. World Anti-erectile Dysfunction (ED) Drugs Production Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 33. World Anti-erectile Dysfunction (ED) Drugs Production Value Market Share by Type in 2022
Figure 34. Sildenafil (Viagra)
Figure 35. Vardenafil (Levitra, Staxyn)
Figure 36. Tadalafil (Cialis)
Figure 37. Avanafil (Stendra)
Figure 38. Udenafil (Zydena)
Figure 39. Others
Figure 40. World Anti-erectile Dysfunction (ED) Drugs Production Market Share by Type (2018-2029)
Figure 41. World Anti-erectile Dysfunction (ED) Drugs Production Value Market Share by Type (2018-2029)
Figure 42. World Anti-erectile Dysfunction (ED) Drugs Average Price by Type (2018-2029) & (US$/Unit)
Figure 43. World Anti-erectile Dysfunction (ED) Drugs Production Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 44. World Anti-erectile Dysfunction (ED) Drugs Production Value Market Share by Application in 2022
Figure 45. Hospital
Figure 46. Retail Pharmacy
Figure 47. Clinic
Figure 48. Online Pharmacy
Figure 49. World Anti-erectile Dysfunction (ED) Drugs Production Market Share by Application (2018-2029)
Figure 50. World Anti-erectile Dysfunction (ED) Drugs Production Value Market Share by Application (2018-2029)
Figure 51. World Anti-erectile Dysfunction (ED) Drugs Average Price by Application (2018-2029) & (US$/Unit)
Figure 52. Anti-erectile Dysfunction (ED) Drugs Industry Chain
Figure 53. Anti-erectile Dysfunction (ED) Drugs Procurement Model
Figure 54. Anti-erectile Dysfunction (ED) Drugs Sales Model
Figure 55. Anti-erectile Dysfunction (ED) Drugs Sales Channels, Direct Sales, and Distribution
Figure 56. Methodology
Figure 57. Research Process and Data Source


More Publications